Halozyme Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Aug 23 | Sell€801,235 | James Daly | Individual | 20,000 | €40.08 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,741 | 0.0178% |
State or Government | 48,164 | 0.0376% |
Individual Insiders | 1,286,224 | 1% |
Institutions | 126,697,996 | 98.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,630,963 | €671.7m | 2.83% | 0.01% | |||
13,259,514 | €478.1m | 1.17% | 0.01% | |||
6,689,058 | €241.2m | -13.3% | 0.21% | |||
6,475,549 | €233.5m | 4.28% | 0.01% | |||
3,709,599 | €133.8m | -14.2% | 3.22% | |||
3,463,694 | €124.9m | 3.19% | 0.04% | |||
3,282,640 | €118.4m | -4.69% | 0.14% | |||
2,919,763 | €105.3m | 4.75% | 0.01% | |||
2,730,408 | €98.4m | -8.81% | 0.01% | |||
2,226,538 | €80.3m | -5.02% | 0.77% | |||
1,983,916 | €71.5m | 517% | 0.06% | |||
1,973,744 | €71.2m | -1.71% | 0.01% | |||
1,921,659 | €69.3m | -4.6% | 0.14% | |||
1,812,344 | €65.3m | 3.24% | 0.02% | |||
1,736,122 | €62.6m | 0% | 0.01% | |||
1,613,113 | €58.2m | 9.94% | 0.01% | |||
1,576,083 | €56.8m | 3.17% | 0.69% | |||
1,518,455 | €54.7m | 4.38% | 0.82% | |||
1,389,837 | €50.1m | -11.4% | 0.01% | |||
1,387,613 | €50.0m | -1.66% | 0.01% | |||
1,215,769 | €43.8m | 28.2% | no data | |||
1,203,716 | €43.4m | -6.2% | 0.01% | |||
1,163,033 | €41.9m | 250% | 0.06% | |||
1,015,998 | €36.6m | -24.5% | 0.01% | |||
949,324 | €34.2m | -2.13% | 0.05% |